Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
McKesson
US Department of Justice
US Army
Johnson and Johnson
Medtronic
Express Scripts
Fuji
Cerilliant

Generated: December 12, 2017

DrugPatentWatch Database Preview

Dexcel Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for DEXCEL PHARMA, and when can generic versions of DEXCEL PHARMA drugs launch?

DEXCEL PHARMA has six approved drugs.

There is one US patent protecting DEXCEL PHARMA drugs on DEXCEL PHARMA drugs in the past three years.

There are nine patent family members on DEXCEL PHARMA drugs in eight countries and twelve supplementary protection certificates in five countries.

Summary for Dexcel Pharma

International Patents:9
US Patents:1
Tradenames:5
Ingredients:5
NDAs:6
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Dexcel PharmaPERIOCHIPchlorhexidine gluconateTABLET;DENTAL020774-001May 15, 1998RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Dexcel PharmaLEVETIRACETAMlevetiracetamTABLET, EXTENDED RELEASE;ORAL202167-001Sep 4, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Dexcel PharmaLEVETIRACETAMlevetiracetamTABLET, EXTENDED RELEASE;ORAL202167-002Sep 4, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Dexcel PharmaOMEPRAZOLEomeprazoleTABLET, DELAYED RELEASE;ORAL022032-001Dec 4, 2007OTCYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Dexcel PharmaLANSOPRAZOLElansoprazoleTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL208025-001Jun 7, 2016OTCNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Dexcel PharmaDONEPEZIL HYDROCHLORIDEdonepezil hydrochlorideTABLET;ORAL203713-001Feb 19, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Dexcel PharmaOMEPRAZOLEomeprazoleTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL209400-001Jul 5, 2017OTCYesNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Dexcel Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Dexcel PharmaPERIOCHIPchlorhexidine gluconateTABLET;DENTAL020774-001May 15, 1998► Subscribe► Subscribe
Dexcel PharmaPERIOCHIPchlorhexidine gluconateTABLET;DENTAL020774-001May 15, 1998► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for DEXCEL PHARMA drugs

Drugname Dosage Strength Tradename Submissiondate
omeprazoleDelayed-release Tablets20 mgOMEPRAZOLE6/3/2015

Non-Orange Book Patents for Dexcel Pharma

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,255,878Stable benzimidazole formulation► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Dexcel Pharma Drugs

Country Document Number Estimated Expiration
Israel130602► Subscribe
Israel147232► Subscribe
Canada2377605► Subscribe
Spain2304349► Subscribe
World Intellectual Property Organization (WIPO)0078284► Subscribe
Germany60038447► Subscribe
Australia5423200► Subscribe
European Patent Office1187599► Subscribe
Austria390119► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Dexcel Pharma Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
11/016Ireland► SubscribePRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE MODIFIED-RELEASE TABLETS; NAT REGISTRATION NO/DATE: PA0970/060/001 20101221; FIRST REGISTRATION NO/DATE: PL17901/0263-0001 20101105
C/GB01/006United Kingdom► SubscribePRODUCT NAME: ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE; REGISTERED: SE 15945 20000310; SE 15946 20000310; UK PL 17901/0068-0069 20000727
1998Austria► SubscribePRODUCT NAME: DONEPEZIL UND SEINE PHARMAKOLOGISCH ANNEHMBAREN SALZE, INSBESONDERE DONEPEZIL HYDROCHLORID; NAT. REGISTRATION NO/DATE: 1-22056, 1-22057 19970728; FIRST REGISTRATION: GB PL105550006, PL105550007 19970214
00C/032Belgium► SubscribePRODUCT NAME: LEVETIRACETAM; NAT. REGISTRATION NO/DATE: EU/1/00/146/001 20000929; FIRST REGISTRATION: CH 55297 20000329
12/048Ireland► SubscribePRODUCT NAME: A COMBINATION PRODUCT COMPRISING ASPIRIN AND ESOMEPRAZOLE MAGNESIUM TRIHYDRATE; NAT REGISTRATION NO/DATE: PA 970/063/001 20120831; FIRST REGISTRATION NO/DATE: 5402359; 5402367 5402375 20110812
C0021Belgium► SubscribePRODUCT NAME: LANSOPRAZOLE; NAT. REG.: 150 S 539 F 4 19921119; FIRST REG.: FR 333 412.1 19901211
00028Netherlands► SubscribePRODUCT NAME: LEVETIRACETAM; REGISTRATION NO/DATE: EU/1/00/146/001 - EU/1/00/146/026 20000929
C/GB97/023United Kingdom► SubscribePRODUCT NAME: DONEPEZIL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, INCLUDING THE HYDROCHLORIDE; REGISTERED: UK PL 10555/0006 19970214; UK PL 10555/0007 19970214
C/GB11/015United Kingdom► SubscribePRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105
14/008Ireland► SubscribePRODUCT NAME: DEXLANSOPRAZOLE OR A SALT THEREOF; NAT REGISTRATION NO/DATE: PA1864/001/001-002;PA1864/002/001-002 20131125; FIRST REGISTRATION NO/DATE: 47911 47912 47913 47914 20130919
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Chubb
Mallinckrodt
QuintilesIMS
Cantor Fitzgerald
Argus Health
US Army
Healthtrust
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot